Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
New 375mg vial addresses critical dosing gap for adult and pediatric patients living with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma CAMBRIDGE,... Read more.
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies... Read more.
Melio Launches Agent Mel, an AI-Powered Assistant to Streamline Business Financial Decision-Making
Conversational, Embedded Agent Helps Accountants, Bookkeepers, and SMBs Quickly Access Critical Payment Information and Save Time NEW YORK–(BUSINESS WIRE)–Melio,... Read more.
Sokin Secures $100M in Growth Financing From Oxford Finance
Debt Facility will fund further growth ambitions and advancement in embedded payments capabilities Oxford Finance backs Sokin’s profitable growth and global expansion... Read more.
MSCI Reports Financial Results for Fourth Quarter and Full Year 2025
NEW YORK–(BUSINESS WIRE)–MSCI Inc. (“MSCI” or the “Company”) (NYSE: MSCI), announced its financial results for the three months ended December... Read more.
Granite Announces Timing of Earnings Release and Investor Conference Call
WATSONVILLE, Calif.–(BUSINESS WIRE)–Granite (NYSE: GVA) will release financial results for the quarter and fiscal year ended December 31, 2025, before... Read more.
Stellar Bancorp, Inc. Reports Fourth Quarter 2025 Results
HOUSTON–(BUSINESS WIRE)–Stellar Bancorp, Inc. (the “Company” or “Stellar”) (NYSE: STEL) today reported net income of $26.1 million, or diluted... Read more.
Nidec Announces Establishment of “Culture Transformation Lab”
– Transformation into a Trustworthy and Sincere Company We Can All Take Pride In – KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO:... Read more.
Nidec Announces Disclosure of the Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026, Exceeding 45 Days After the Quarter-End
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) hereby announces that the scheduled disclosure date of... Read more.
Premier Radiology Services Acquires NRAD, Further Expanding Teleradiology Capabilities
DEERFIELD BEACH, Fla.–(BUSINESS WIRE)–Premier Radiology Services (Premier) is pleased to announce the acquisition of National Radiology Solutions (NRAD),... Read more.